Experiments for taxon Periploca aphylla (ASCLEPIADACEAE)

Experiments (40 results)

Filters
Worktypes (15)
14
11
7
6
4
4
3
3
2
2
2
2
2
2
2
No match
Pharmacology (10)
16
3
2
2
2
1
1
1
1
11
No match
Compounds (22)
9
8
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
17
No match
Organisms (13)
18
5
3
3
2
2
1
1
1
1
1
1
1
No match
40 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
73495
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTICRUSTACEAN ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
258962
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
258954
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
1148916
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
258965
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
73492
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
1148919
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
258951
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
258958
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
258957
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
258964
PHARMACOLOGY OF COMPOUND - IN VITRO
GLUCOSIDASE INHIBITION
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
258953
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
258963
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
867867
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
OOOO
258952
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
73493
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
1123742
MEDICINAL FOLKLORE REPORTED FOR
CARDIOTONIC ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
51215
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Periploca aphylla (ASCLEPIADACEAE)
1148920
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
51217
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
313822
MEDICINAL FOLKLORE REPORTED FOR
LAXATIVE EFFECT
Periploca aphylla (ASCLEPIADACEAE)
1148921
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
258967
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Periploca aphylla (ASCLEPIADACEAE)
SITOSTEROL,BETA:
258956
PHARMACOLOGY OF COMPOUND - IN VITRO
GLUCOSIDASE INHIBITION
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
73494
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
50660
ISOLATION AND IDENTIFICATION OF
Periploca aphylla (ASCLEPIADACEAE)
OLEANOLIC ACIDLUPEOLDAUCOSTEROLMASLINIC ACID
844042
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
OOOOOOO
258950
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
844147
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
OOOOOOO
51216
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Periploca aphylla (ASCLEPIADACEAE)
73491
VOUCHER SPECIMEN REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
258955
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-EN-3-BETA-OCTADECANOATE,6-ALPHA-HYDROXY:
258961
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
1276194
ISOLATION AND IDENTIFICATION OF
Periploca aphylla (ASCLEPIADACEAE)
OLEANOLIC ACIDURSOLIC ACIDLUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:STIGMASTEROLURS-12-EN-28-OIC ACID,2-BETA-3-BETA-23-TRIHYDROXY:LUP-20(29)-ENE,6-ALPHA-HYDROXY: 3-BETA-OCTADECANOATE
258966
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Periploca aphylla (ASCLEPIADACEAE)
LUPEOL
1148915
VOUCHER SPECIMEN REPORTED FOR
Periploca aphylla (ASCLEPIADACEAE)
258960
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
258959
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
LUP-20(29)-ENE,3-BETA-6-ALPHA-DIHYDROXY:
1148918
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)
1148917
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Periploca aphylla (ASCLEPIADACEAE)